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ABSTRACT The structural basis of species specificity of
transmissible spongiform encephalopathies, such as bovine
spongiform encephalopathy or ‘‘mad cow disease’’ and
Creutzfeldt–Jakob disease in humans, has been investigated
using the refined NMR structure of the C-terminal domain of
the mouse prion protein with residues 121–231. A database
search for mammalian prion proteins yielded 23 different
sequences for the fragment 124–226, which display a high
degree of sequence identity and show relevant amino acid
substitutions in only 18 of the 103 positions. Except for a
unique isolated negative surface charge in the bovine protein,
the amino acid differences are clustered in three distinct
regions of the three-dimensional structure of the cellular form
of the prion protein. Two of these regions represent potential
species-dependent surface recognition sites for protein–
protein interactions, which have independently been impli-
cated from in vitro and in vivo studies of prion protein
transformation. The third region consists of a cluster of
interior hydrophobic side chains that may affect prion protein
transformation at later stages, after initial conformational
changes in the cellular protein.
Transmissible spongiform encephalopathies (TSE) are neuro-
degenerative diseases for which there is evidence that they are
related to a novel, so far unique, infectious agent, the prion (1,
2). TSEs have been reported to occur as infectious, inherited,
and spontaneous diseases. Following the ‘‘protein-only hy-
pothesis’’ (2, 3) the causative agent is a pathogenic conforma-
tion of the prion protein (PrP). PrP is ubiquitous in mammalian
cells in a benign, cellular conformation (PrPC). In rare cases it
may be transformed into the infectious scrapie conformation
(PrPSc), which forms insoluble, protease-resistant aggregates
in the brain of affected individuals (4, 5). The most widely
discussed TSEs are Creutzfeldt–Jakob disease in humans,
scrapie in sheep, and bovine spongiform encephalopathy.
Other human prion diseases include kuru, the Gerstmann–
Sträussler–Scheinker syndrome, and fatal familial insomnia.
With the background of the ‘‘mad cow crisis’’ in Europe,
questions relating to the relative ease of infection between
different individuals of the same species or between different
species have attracted intensive interest, in particular regard-
ing possible transmission of bovine spongiform encephalopa-
thy from cows to humans through the food chain (6, 7). A
species barrier for prion infection has indeed been convinc-
ingly documented (4, 5) and found to vary widely depending
on the pair of species involved and the direction of transmis-
sion. Typical laboratory tests involve inoculation of mice or
hamsters by injection of infectious material directly into the
brain, and work with transgenic animals has led to the iden-
tification of polypeptide segments in PrP that appear to
dominate the species barrier (surveyed in refs. 4 and 8). There
is a general consensus that interspecies transfer, when com-
pared with infection within one species, is inefficient and
occurs, if at all, only after prolonged incubation times. How-
ever, uncertainty remains with regard to the stringency of the
transmission barrier for certain pairs of species. In vitro studies
of the cell-free conversion of PrPC to protease-resistant forms
are overall in support of the aforementioned in vivo data (8).
The present paper correlates biological and biochemical
data on the species barrier with the refined NMR structure of
the recombinant C-terminal domain of the mouse PrP with
residues 121–231 [PrP(121–231)] (9). The pairwise sequence
identity for this domain of about 90% among mammalian
species (10) implies that all these species should have identical
three-dimensional PrP(121–231) folds (11); this is supported
by the modeling of the three-dimensional structures of
PrP(121–231) from different species in our laboratory (un-
published data). Within the framework of the protein-only
hypothesis the contributions to the species barrier from the
polypeptide segment 121–231 then must be related to part or
all of the amino acid replacements between the PrP of a given
pair of species. The aforementioned in vivo inoculation studies
and in vitro conversion experiments support the hypothesis that
a critical step of infectious transmission of transmissible spon-
giform encephalopathies involves a specific intermolecular
contact between PrPC and PrPSc (4, 5, 8). From additional work
with mouseyhuman chimeras, interactions of PrPC with a so far
unknown additional protein X also have been postulated to
contribute to efficient conversion (12). Here, we map the
polypeptide segment 124–226 of all known mammalian PrP
sequences (10) onto the three-dimensional structure of mouse
PrP(121–231) and evaluate potential effects on protein–
protein interactions with PrPC†.
METHODS
The structure of mouse PrP(121–231) used for the present
analysis is a refinement of the previously reported NMR
structure (9), which is based on an input of 1,586 nuclear
Overhauser effect distance constraints. The structure deter-
The publication costs of this article were defrayed in part by page charge
payment. This article must therefore be hereby marked ‘‘advertisement’’ in
accordance with 18 U.S.C. §1734 solely to indicate this fact.
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Abbreviations: PrP, prion protein; PrP(121–231), recombinant C-
terminal domain of the mouse Prp with residues 121–231; PrPC,
cellular form of PrP; PrPSc, scrapie form of PrP.
Data deposition: The atomic coordinates of mouse PrP(121–231) have
been deposited in the Protein Data Bank, Brookhaven National
Laboratory, Upton, NY 11973 (reference 1AG2).
*To whom reprint requests should be addressed.
†Within the framework of the ‘‘protein-only’’ hypothesis, various
different mechanisms are possible by which amino acid exchanges in
the PrP sequence could cause a barrier for transmission between
difference species. These include, for example, the presently dis-
cussed situation that the amino acid exchange affects a binding site
in PrPC for PrPSc or protein X, that it belongs to a region in PrPSc,
which interacts with PrPC, or that it is involved in subunit–subunit
contacts in oligomeric PrPSc. The discussions in this paper are focused
entirely on the influence of amino acid substitutions on structure and
intermolecular interactions of PrPC.
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mination will be described elsewhere (unpublished work). Key
characteristics of the refined structure include that there are
no residual violations of the aforementioned distance con-
straints in excess of 0.1 Å and that the well defined regions
comprise residues 124–166 and 172–226, for which a root mean
square distance for the backbone atoms N, Ca, and C9 of the
20 final conformers to their mean of 0.8 6 0.1 Å was obtained.
Figs. 2, 3, and 4 of this paper show an energy-refined mean
structure of mouse PrP(121–231), of which the atom coordi-
nates have been deposited in the Brookhaven Protein Data
Bank (accession code 1AG2).
Information on mammalian PrP sequences was collected
from the protein databases SWISSPROT (13) and the nucleic
acid database GENEMBL. The structure comparisons in the
following section were based on the sequence alignment of
Schätzl et al. (10), which is not a critical issue because the
pairwise sequence identity is of the order of 90% for all
combinations of mammalian species considered.
RESULTS
A group of 23 PrP sequences (Fig. 1) was identified in a
database search for entries with over 60% identity and an
overlap of at least 60 residues with the polypeptide fragment
124–226 of the mouse PrP. The following additional selection
criteria were used to ensure that the focus was on statistically
reliable data: (i) In the presence of the complete sequence,
partial sequences of the same species were dropped. (ii) Where
different sequences were reported for the same species, only
the one with the smallest number of changes relative to the
mouse sequence was retained. (iii) All sequences were omitted
that differ from the sequence of the mouse protein only by
conservative mutations in positions where all other species in
the databases show identity with the mouse protein (see Fig.
1 legend). (iv) The sequence of the marsupial possum was not
included because its evolutionary distance to all other mam-
mals is outstandingly large (see Table II A, B. in ref. 14).
Overall, as indicated in the bottom line of the figure, the 23
sequences in Fig. 1 contain 22 positions with amino acid
replacements. Of these, 18 are grouped into the classes A, B,
C, and D on the basis of their locations in the three-
dimensional structure of PrP(121–231) (Fig. 2) and the chem-
ical properties of the amino acid residues (Figs. 3 and 4). The
three-dimensional fold of PrP(121–231) includes three helices
with residues 144–154, 175–193, and 200–219, and an antipa-
rallel b-sheet with residues 128–131 and 161–164 (Figs. 1 and
FIG. 1. Sequence comparisons of the fragment 124–226 of mammalian PrP (see text for the selection criteria used), with the mouse sequence
as a reference. At the top the locations of the regular secondary structures in mouse PrP(121–231) are indicated, and the sequence numbers refer
to the residue under the third digit. The bottom line gives a classification of the observed variable sites into six classes A (blue), B (magenta), C
(green), D (orange), 1, and 2 (see text). In addition to the 23 sequences listed here, SWISSPROT and GENEMBL provide three sequences (chimpanzee,
gibbon, and siamang) that differ from gorilla only by the exchange N171S, two sequences that differ from that of Presbytis francoisi only by the
exchanges N159S and I182V (squirrel monkey) and D144E (sooty mangabey), respectively; for all these sites no amino acid substitutions are
observed in any other of the mammalian sequences. There are further two mouse sequences with the replacements M134V and T190V, respectively,
relative to the mouse sequence listed here, two bovine sequences with the replacements G143S and G143SyM201K, respectively, a goat sequence
with I139M, a pig sequence with N143S, and a squirrel monkey sequence with the exchange R164K.
FIG. 2. Mapping of the classes of A, B, C, and D of amino acid
variability in mammalian PrP (Fig. 1) onto the refined NMR structure
of the mouse PrP(121–231). The structure shown here and in the
following figures is an energy-refined mean structure. The backbone
is represented in white, and the single disulfide bridge Cys-179–Cys-
214 is yellow. Side chains of the mouse PrP in the variable sites are blue
for class A, magenta for B, green for C, and orange for D. This and
all other color figures were prepared with the program MOLMOL (15).
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2). The helices 2 and 3 are linked by the disulfide bond
Cys-179–Cys-214 (Fig. 2) and represent a stable scaffold for
the global molecular structure (9). The class A sites form a
dense cluster of nine residues in the loop between the second
b-strand and the second helix (positions 164, 166, 168, 170, and
174), and near the C terminus (positions 215, 219, 220, and
223) (upper right in Fig. 2). Class B includes the five hydro-
phobic residues 138, 139, 184, 203, and 205, which are located
in the interface between the first helix and the remainder of the
protein. Class C sites include positions 145 and 155 at the two
ends of helix 1, and the position 143 immediately preceding this
helix. Class D includes only the exchange Q186E in the bovine
protein, which introduces an isolated surface-exposed negative
charge that might affect intermolecular interactions. The
position 225 (‘‘2’’) near the C terminus and three positions with
largely conservative single-species amino acid substitution
(‘‘1’’) are not shown in Fig. 2 and are not further considered.
In class A the amino acid replacements in positions 168, 219,
220, and 223 (Fig. 3a) involve changes in the electrostatic
charge of the side chains and may modify long-range forces
effective in intermolecular recognition. Fig. 3 b-d shows the
electrostatic surface potential for the mouse, human, and
sheep proteins, where this molecular region has a total net
charge of 21, 23, and 0, respectively. In total, seven of the nine
sequence positions in class A contain polar or charged side
chains in all species of Fig. 1. The class A residues thus form
a surface region of PrPC that has the potential to function as
a selective protein–protein interaction site. It is readily appar-
ent from inspection of the NMR structure of mouse PrP(121–
231) that many of the A-type amino acid exchanges will cause
different surface hydrogen bonding patterns in the PrP from
different species, and some of the amino acid replacements
also might lead to different hydrogen bonding with a docked
FIG. 3. Molecular surface area of PrP(121–231) containing exchangeable residues of class A. The viewing angle is in the plane of Fig. 2 from
the upper right corner. The polypeptide fragments 161–179 and 214–226 are shown. (a) The A-type residues in the mouse sequence are labeled
and drawn as ball-and-stick models into the NMR structure, using yellow coloring for hydrophobic aliphatic residues, red for polar residues, and
blue for positively charged residues. The backbone is white, the four chain ends are identified with white lettering, the cysteines 179 and 214 are
green, and the other side chains are colored by atom type, with carbon gray, oxygen red, and nitrogen blue. (b–d) Solvent-accessible surface in
three species containing different electrostatic charges. The surface is colored according to the electrostatic potential, with blue for positive charges
and red for negative charges. The centrally located red area is common to PrPC from all three species and corresponds to the invariant residues
Asp-167 and Glu-221 (see Fig. 1). (b) NMR structure of mouse PrPC, total charge of the molecular region shown 21 (same as a). This represents
also bovine PrPC, which differs in this area only by the two conservative exchanges V215I and K220R (Fig. 1). (c) Model of human PrPC, total
charge 23; with respect to b Val-166 has been changed to Met, Gln-168 to Glu, Val-215 to Ile, Gln-219 to Glu, and Lys-220 to Arg. (d) Model
of sheep PrPC, total charge 0; with respect to b Gln-168 has been changed to Arg, Val-215 to Ile, and Lys-220 to Arg.
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molecule. Overall, although the amino acid substitutions be-
tween different species can be expected to preserve the global
shape of this putative binding site, they may modify its
specificity for both long-range electrostatic interactions and
short-range hydrogen bonding with other proteins.
Classes B and C contain residues from helix 1, part of helices
2 and 3, and helix-adjacent loops (Fig. 4a). The group C sites
are related to a special feature of helix 1, which includes four
largely or partially solvent-exposed aromatic side chains in the
mouse sequence (Fig. 4b). With the sole exception of Met-154
all other side chains of this helix have polar character (Fig. 4b),
and the positions 146–148, 151, and 152 actually contain
charged side chains (Fig. 1). The combination of long-range
electrostatic potentials, high hydrogen bonding propensity,
and the presence of exposed aromatic residues on the solvent-
accessible surface of helix 1 again represents structural fea-
tures of a surface area that could well function as a specific
recognition site for other proteins. Replacement of the C-type
amino acid residues 145 and 155, in particular replacement of
the unusual surface-exposed Trp-145, can be expected to
modify the specificity of intermolecular interactions in this
molecular region.
In all proteins of Fig. 1 the type B sites contain exclusively
hydrophobic side chains of Val, Leu, Ile, or Met, which are in
contact with other hydrophobic residues (Fig. 4a). Because of
their limited surface accessibility, and considering the absence
of electrostatic charges and hydrogen bonding propensity, the
molecular region containing these sites is not reminiscent of a
potential binding site that would mediate intermolecular in-
teractions of the folded PrPC molecule. However, upon limited
conformational rearrangement of PrPC, for example, by un-
folding of the helix 1 (see ref. 9), several of these hydrophobic
residues would become accessible and thus could support
propagation of self-association of PrP. The observation in the
spatially neighboring positions 184 and 203 (Fig. 4a) that
replacement of Ile-184 by Val correlates in all but two species
with the replacement of Val-203 by Ile or Met (Fig. 1), appears
to further support the view that class B amino acid exchanges
leave the PrPC surface properties largely unperturbed.
In summary, Fig. 2 shows that large regions of PrP(121–231)
are not affected by species variations. These include the
b-sheet, the central two turns of the first helix, the C-terminal
two turns of the second helix, the loop linking the helices 2 and
3, and the third and fourth turn of the third helix. Part of this
conservation can readily be explained by requirements to
maintain local three-dimensional PrPC structure. However,
some conservation also may be needed to secure further
intramolecular or intermolecular interactions, for example,
with the polypeptide segment 23–120 in intact PrPC, with the
cell surface to which the PrP is attached, or with a natural
ligand. The high frequency of amino acid exchanges between
different species in the region of the three-dimensional struc-
ture that contains the class A residues makes this region a likely
candidate for a specific binding site, where amino acid re-
placements would affect intermolecular recognition with PrPC
(Fig. 3). The helix 1 with the C-type amino acid substitutions
forms another potential binding site (Fig. 4b) on the opposite
molecular surface (Fig. 2), where replacement of solvent-
exposed aromatic side chains between different species would
be expected to modify the specificity by which this region is
recognized by other proteins.
DISCUSSION
Inoculation experiments with chimeric PrP suggested two
protein binding sites in the PrP amino acid sequence. These
experiments so far have been the only information available for
mapping of species-related differences in PrPC. One of these
binding sites would be located in the segment with residues
96–167, which would bind an infecting PrPSc particle. The
second site would be composed of residues outside of this
segment, which could possibly interact with the postulated
protein X (4, 12). The variable C-type residues in helix 1 hence
would contribute to a protein surface area that might be
involved in interactions with PrPSc, and the cluster of type A
residues would be a potential binding site for protein X. The
in vitro PrPC conversion experiments of Kocisko et al. (8)
suggested that the hamsterymouse species barrier is dependent
FIG. 4. Location of the B- and C-class amino acid exchange sites
(Fig. 1) in the NMR structure of mouse PrPC. (a) The view is along
the axis of the first helix (on the left in Fig. 2) in the direction from
Trp-145 in the front to Tyr-155 in the back. The display includes the
residues 133–159 and 179–214, with helix 1 and its connections to the
b-sheet, the loop connecting the helices 2 and 3, and these two helices
up to the disulfide link 179–214. Variable residues are represented by
ball-and-stick models and labeled, with yellow coloring for hydropho-
bic aliphatic side chains, red for polar residues, and orange for
aromatic residues. The polypeptide backbone is white, the four chain
ends are identified with white lettering, hydrophobic side chains are
yellow, the aromatic side chains orange and the disulfide bridge green.
(b) Space-filling model of the three-dimensional structure formed by
residues 124–226. The viewing angle is in the plane of Fig. 2 from the
left, so that the first helix of residues 145–155 runs from top to bottom
in the foreground. The side chains of helix 1 are: orange, Tyr and Trp;
red, Asp and Glu; blue, Arg; cyan, Asn-153; and yellow, Met-154. For
the rest of the protein the polypeptide backbone is white and the side
chains are gray.
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on the three amino acid exchanges M139I, N155Y, and N170S
(Fig. 1). It is striking that the segment 96–167 as well as the
group of residues 139y155y170 includes at least one residue
from each of the classes A, B, and C (Fig. 1). Other experi-
mental data attribute an exclusive role for the species barrier
between mouse and hamster to position 139 (16): The substi-
tution of Met in hamster PrP by Ile in mouse PrP appears to
be sufficient to protect hamster from infection by mouse PrPSc.
This would place the critical structural feature for the species
barrier in the interface between helix 1 and the protein core
(Figs. 2 and 4a). The residue 139 presumably would become
operational only after initial conformational transitions of
PrPC induced by complexation with PrPSc and possibly protein
X (9). The present structural observations can be expected to
support future refinement of in vivo and in vitro experiments
with chimeric PrP.
The class D exchange Q186 E in bovine PrP introduces a
negative electrostatic charge in a surface location that is clearly
separated in space from the two presumed binding sites
characterized by A- and C-type residues, respectively (Fig. 2).
Interestingly, recent results indicate the presence of Glu-186
also in the related species Watussi, Banteng, and Wisent (H.
Schätzl, personal communication). The newly determined PrP
sequences of the house dog, the Canadian wolf, and the dingo
(H. Schätzl, personal communication) further extend the
available information on D-type mutation sites, because the
otherwise strictly conserved Asn-159 (Fig. 1) is replaced by
Asp, and this negative charge is located in close spatial
proximity to position 186 (Fig. 2). This leaves the intriguing
option that a third variable surface area in PrPC might emerge
by further extension of the sequence database, and that this site
might be functional in the species barrier with cattle, including
possibly also transmission of disease from bovine spongiform
encephalopathy-infected cows to other species.
Finally, although the NMR structure of mouse PrP(121–
231) represents only part of PrPC and the ensemble of all
accumulated data indicates that N-terminal parts of the se-
quence also may influence the species barrier (for example, see
refs. 4 and 5), there is evidence that the data presented in this
paper are highly relevant with regard to the intact system, and
that PrP(121–231) has a key part in PrPC physiology (8, 12, 16).
Structure predictions and experimental observations (9, 17)
indicate that PrP(121–231) is probably the only polypeptide
segment with a global fold in intact PrPC, and initial NMR
studies with intact PrPC performed in our laboratory indicate
that the segment 121–231 in the intact protein has the same
fold as in PrP(121–231) (unpublished data).
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